Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIN457 (Secukinumab) PoC in Psoriasis
NCT00669916Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Primary completion
- Nov 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of secukinumab in plaque psoriasis, sponsored by Novartis. Started Feb 2007; status: completed.
02
Drugs
secukinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00669916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669916.